Use of dextran sulfate having an average molecular weight below 10000 DA for inducing angiogenesis in a subject

摘要

The present embodiments relate to the use of dextran sulfate having an average molecular weight below 10 000 Da for inducing angiogenesis in a subject and for increasing blood flow in a subject suffering from ischemia.